Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03122158|
Recruitment Status : Unknown
Verified April 2017 by Muharrem Burak Baytunca, Erzurum Regional Training & Research Hospital.
Recruitment status was: Active, not recruiting
First Posted : April 20, 2017
Last Update Posted : April 20, 2017
Erzurum Regional Training & Research Hospital
Information provided by (Responsible Party):
Muharrem Burak Baytunca, Erzurum Regional Training & Research Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||September 15, 2018|
|Estimated Study Completion Date :||December 15, 2018|
Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004 Jun;161(6):1079-83.
Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):721-729. doi: 10.1097/CHI.0b013e3181a2b304.